ELI SHALENBERG
NEW YORK, NY NPI 1013234202
Browse related groups: NY Neurocrine BioSciences, Inc. All categories
General Payments — all program years on this page
$7,848.91
- Category: General Payments
- Program years: PY2018–2022
- Record count: 360
- As of (CMS publication): 2026-01-23
Latest program year (PY2022): $226.01 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2022) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $226.01 | 8 |
By paying entity
Latest program year (PY2022) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Neurocrine BioSciences, Inc. | $95.96 | 2 |
| Teva Pharmaceuticals USA, Inc. | $47.83 | 2 |
| ABBVIE INC. | $27.65 | 1 |
| Otsuka America Pharmaceutical, Inc. | $20.44 | 1 |
| JAZZ PHARMACEUTICALS INC. | $18.67 | 1 |
| EISAI INC. | $15.46 | 1 |
By program year
Records — PY2022 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 891574869 | ABBVIE INC. | $27.65 | 02/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 926011743 | EISAI INC. | $15.46 | 01/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 929337787 | Otsuka America Pharmaceutical, Inc. | $20.44 | 01/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 954284261 | JAZZ PHARMACEUTICALS INC. | $18.67 | 01/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 954419289 | Teva Pharmaceuticals USA, Inc. | $24.02 | 01/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 954419323 | Teva Pharmaceuticals USA, Inc. | $23.81 | 02/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 963369617 | Neurocrine Biosciences, Inc. | $23.33 | 01/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 963369657 | Neurocrine Biosciences, Inc. | $72.63 | 03/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.